1Y returns
+7.64%
cat 12.11%3Y CAGR
+21.46%
cat 22.73%5Y CAGR
—
cat 13.72%Std deviation 3Y
+16.61%
cat 16.29%In plain English
ITI Pharma and Healthcare Fund is a Sectoral / Thematic scheme from ITI. The portfolio is ~98% in equities. 3-year CAGR: about 21.5%. Volatility is typical for equity — 20–30 % drawdowns happen during market stress. Worst historical drawdown: -18% in Jun 2022, recovered in 12 months. Wrong fit if you need this money in less than 7 years.
Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.
NAV history
NAV (Direct-Growth)
₹19.3354
Last 1Y
+8.23%
Drawdown stories
The crashes you should know about — and how long the fund took to recover.
Jun 2022
-17.7%Peak ₹10.34 on 13 Jan 2022 → trough ₹8.51 on 17 Jun 2022 (5 months down).
Mar 2025
-17.1%Peak ₹18.78 on 2 Jan 2025 → trough ₹15.58 on 3 Mar 2025 (2 months down).
Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.
Honesty score
A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.
Honesty score
4 / 5
Solid scheme on the dimensions we check. No red flags.
Expense ratio
0.68% — typical for category.
AUM size
₹238 Cr.
Sector concentration
Top 3 sectors = 98.0% — heavy concentration risk.
Performance
Returns for various periods, with category average and peer rank.
Portfolio composition
Asset allocation
- Equity98.01%
- Cash1.99%
By market cap
- Large cap47.29%
- Mid cap30.11%
- Small cap28.74%
Concentration
Holdings
39
Avg market cap
₹81.3K Cr
Top 10 stocks
58.94%
Top 5 stocks
38.84%
Top 3 sectors
98.01%
Top holdings
Top 15 positions by weight, latest disclosure.
- 1—14.25%
Sun Pharmaceuticals Industries Ltd
- 1—11.80%
Sun Pharmaceuticals Industries Ltd
- 2—8.77%
Divi's Laboratories Ltd
- 2—8.43%
Divi's Laboratories Ltd
- 3—6.60%
Apollo Hospitals Enterprise Ltd
- 3—6.20%
Apollo Hospitals Enterprise Ltd
- 4—5.50%
Max Healthcare Institute Ltd Ordinary Shares
- 5—5.28%
Torrent Pharmaceuticals Ltd
- 4—5.06%
Laurus Labs Ltd
- 6—4.99%
Aurobindo Pharma Ltd
- 5—4.90%
Torrent Pharmaceuticals Ltd
- 6—4.90%
Max Healthcare Institute Ltd Ordinary Shares
- 7—4.28%
Aurobindo Pharma Ltd
- 7—4.20%
Lupin Ltd
- 8—3.98%
Dr Reddy's Laboratories Ltd
Fundamentals (vs category)
Portfolio-weighted ratios, compared with the category average.
- P/E ratio41.0241.09-0.07
- P/B ratio5.625.83-0.21
- Price / Sales5.725.71+0.01
- Price / Cash Flow30.3530.54-0.19
- Dividend yield0.58%0.63%-0.05
- Return on equity (ROE)16.24%16.57%-0.33
Risk metrics
Standard deviation, Sharpe, Sortino, Beta — all vs category average.
- 16.6116.61—14.9216.2915.44
Standard deviation
Volatility — lower means steadier returns.
- 0.190.88—0.480.980.58
Sharpe ratio
Risk-adjusted return — higher is better.
- 0.291.46—0.831.710.94
Sortino ratio
Like Sharpe but only counts downside volatility.
- 1.030.98—0.940.950.94
Beta
1 = moves with the market. <1 = less volatile.
Peers in Sectoral / Thematic
Other schemes in the same SEBI category, ranked by AUM.
- ₹36.5K Cr+6.58%+22.72%0.57%
ICICI Prudential India Opportunities Fund
ICICI Prudential
- ₹36.5K Cr+1.48%+18.90%0.57%
ICICI Prudential India Opportunities Fund
ICICI Prudential
- ₹15.8K Cr+6.72%+21.95%0.64%
ICICI Prudential Business Cycle Fund Direct Plan Growth
ICICI Prudential
- ₹15.8K Cr+2.38%+18.99%0.64%
ICICI Prudential Business Cycle Fund Direct Plan Growth
ICICI Prudential
- ₹13.4K Cr-10.00%+10.76%0.86%
ICICI Prudential Technology Fund
ICICI Prudential
- ₹13.4K Cr-21.09%+5.76%0.86%
ICICI Prudential Technology Fund
ICICI Prudential
- ₹10.6K Cr+1.41%+13.88%0.87%
ICICI Prudential Banking and Financial Services Fund
ICICI Prudential
- ₹10.6K Cr-1.94%+11.58%0.87%
ICICI Prudential Banking and Financial Services Fund
ICICI Prudential
Available plans & options
- DirectGrowthITI Pharma and Healthcare Fund - Direct Plan - Growth OptionINF00XX01BO9
- DirectIDCW ReinvestmentITI Pharma and Healthcare Fund - Direct Plan - IDCW OptionINF00XX01BP6
- RegularGrowthITI Pharma and Healthcare Fund - Regular Plan - Growth OptionINF00XX01BL5
- RegularIDCW ReinvestmentITI Pharma and Healthcare Fund - Regular Plan - IDCW OptionINF00XX01BM3
NEW
See your SIP through Indian market history
Pick a fund and a start year — get a 60-second cinematic replay of every crash, boom, and headline with your money in it. Real NAV data, no “assumed 12%” lies.
Try Wealth Time MachineAI · Free
Find what's really inside your funds
Upload your CAS PDF — get instant stock concentration, hidden fund overlap, sector risk, and 3 specific actions, written by AI in plain English.
Run Portfolio X-Ray